Annual Revenue
$130.00 K
-$84.55 M-99.85%
31 December 2023
Summary:
Lyell Immunopharma annual revenue is currently $130.00 thousand, with the most recent change of -$84.55 million (-99.85%) on 31 December 2023. During the last 3 years, it has fallen by -$7.63 million (-98.32%). LYEL annual revenue is now -99.85% below its all-time high of $84.68 million, reached on 31 December 2022.LYEL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$34.00 K
+$21.00 K+161.54%
30 September 2024
Summary:
Lyell Immunopharma quarterly revenue is currently $34.00 thousand, with the most recent change of +$21.00 thousand (+161.54%) on 30 September 2024. Over the past year, it has increased by +$9000.00 (+36.00%). LYEL quarterly revenue is now -99.93% below its all-time high of $48.39 million, reached on 31 December 2022.LYEL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$63.00 K
+$9000.00+16.67%
30 September 2024
Summary:
Lyell Immunopharma TTM revenue is currently $63.00 thousand, with the most recent change of +$9000.00 (+16.67%) on 30 September 2024. Over the past year, it has dropped by -$48.44 million (-99.87%). LYEL TTM revenue is now -99.93% below its all-time high of $84.68 million, reached on 31 December 2022.LYEL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.8% | +36.0% | -99.9% |
| 3 y3 years | -98.3% | -98.8% | -99.4% |
| 5 y5 years | - | - | - |
LYEL Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.8% | at low | -99.9% | +1033.3% | -99.9% | +16.7% |
| 5 y | 5 years | -99.8% | at low | -99.9% | +1033.3% | -99.9% | +16.7% |
| alltime | all time | -99.8% | at low | -99.9% | +1033.3% | -99.9% | +16.7% |
Lyell Immunopharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $34.00 K(+161.5%) | $63.00 K(+16.7%) |
| June 2024 | - | $13.00 K(+333.3%) | $54.00 K(-20.6%) |
| Mar 2024 | - | $3000.00(-76.9%) | $68.00 K(-47.7%) |
| Dec 2023 | $130.00 K(-99.8%) | $13.00 K(-48.0%) | $130.00 K(-99.7%) |
| Sept 2023 | - | $25.00 K(-7.4%) | $48.50 M(+0.0%) |
| June 2023 | - | $27.00 K(-58.5%) | $48.48 M(-42.4%) |
| Mar 2023 | - | $65.00 K(-99.9%) | $84.19 M(-0.6%) |
| Dec 2022 | $84.68 M | $48.39 M(>+9900.0%) | $84.68 M(+116.5%) |
| Sept 2022 | - | $3000.00(-100.0%) | $39.12 M(-6.6%) |
| June 2022 | - | $35.74 M(+6363.1%) | $41.87 M(+378.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $553.00 K(-80.4%) | $8.76 M(-17.8%) |
| Dec 2021 | $10.65 M(+37.3%) | $2.82 M(+2.4%) | $10.65 M(+5.0%) |
| Sept 2021 | - | $2.75 M(+4.8%) | $10.14 M(+19.9%) |
| June 2021 | - | $2.63 M(+7.5%) | $8.46 M(-5.5%) |
| Mar 2021 | - | $2.44 M(+5.8%) | $8.95 M(+15.3%) |
| Dec 2020 | $7.76 M(+1080.5%) | - | - |
| Dec 2020 | - | $2.31 M(+116.1%) | $7.76 M(+42.5%) |
| Sept 2020 | - | $1.07 M(-65.7%) | $5.44 M(+24.5%) |
| June 2020 | - | $3.12 M(+148.2%) | $4.37 M(+248.2%) |
| Mar 2020 | - | $1.26 M | $1.26 M |
| Dec 2019 | $657.00 K | - | - |
FAQ
- What is Lyell Immunopharma annual revenue?
- What is the all time high annual revenue for Lyell Immunopharma?
- What is Lyell Immunopharma annual revenue year-on-year change?
- What is Lyell Immunopharma quarterly revenue?
- What is the all time high quarterly revenue for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly revenue year-on-year change?
- What is Lyell Immunopharma TTM revenue?
- What is the all time high TTM revenue for Lyell Immunopharma?
- What is Lyell Immunopharma TTM revenue year-on-year change?
What is Lyell Immunopharma annual revenue?
The current annual revenue of LYEL is $130.00 K
What is the all time high annual revenue for Lyell Immunopharma?
Lyell Immunopharma all-time high annual revenue is $84.68 M
What is Lyell Immunopharma annual revenue year-on-year change?
Over the past year, LYEL annual revenue has changed by -$84.55 M (-99.85%)
What is Lyell Immunopharma quarterly revenue?
The current quarterly revenue of LYEL is $34.00 K
What is the all time high quarterly revenue for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly revenue is $48.39 M
What is Lyell Immunopharma quarterly revenue year-on-year change?
Over the past year, LYEL quarterly revenue has changed by +$9000.00 (+36.00%)
What is Lyell Immunopharma TTM revenue?
The current TTM revenue of LYEL is $63.00 K
What is the all time high TTM revenue for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM revenue is $84.68 M
What is Lyell Immunopharma TTM revenue year-on-year change?
Over the past year, LYEL TTM revenue has changed by -$48.44 M (-99.87%)